Gene · 11082
ESM1: endothelial cell specific molecule 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ESM1: endothelial cell specific molecule 1. Genes, record 11082. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/11082
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NQ30 | Endothelial cell-specific molecule 1 | 184 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents63
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4705273 A2 | 2026-03-11 | 785 | Q9NQ30 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 10456 | Q9NQ30 | Espacenet |
| WO 2025225410 A | 2025-10-30 | 5 | Q9NQ30 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 4923 | Q9NQ30 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2574 | Q9NQ30 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6301 | Q9NQ30 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6301 | Q9NQ30 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 10456 | Q9NQ30 | Espacenet |
| JP 2025041681 A | 2025-03-26 | 12 | Q9NQ30 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 4923 | Q9NQ30 | Espacenet |
1 to 10 of 63
See all 63 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants576
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ESM1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| ZICES102445 | Gene Expression and Microarrays | 4 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P30DK116074 | Stanford Diabetes Research Center | 3 | 2025 |
| P50CA101942 | DF/HCC Kidney Cancer SPORE (supplement) | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| P01HL141084 | Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology | 2 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 576Source NIH's project files
See all 576 nih grantsPapers2,013
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Influence of Statin Therapy on Markers of Endothelial Dysfunction, Endocan and Endoglin, in Postmenopausal Women-A Prospective Study. | Biomedicines | 2026 | 42792663 | PubTator, text mining | PubMed |
| Diagnostic value of endothelial-specific molecule-1 levels in patients with bone tumors. | Acta Biochim Pol | 2026 | 42787261 | PubTator, text mining | PubMed |
| Correlation analysis of the expression levels of serum endothelial cell adhesion molecule-1 and sirtuin 1 protein in acute respiratory distress syndrome. | J Med Biochem | 2026 | 42781202 | PubTator, text mining | PubMed |
| Allergic rhinitis duration and small-airway dysfunction in adolescents without asthma: a cross-sectional impulse oscillometry study. | J Asthma | 2026 | 42779210 | PubTator, text mining | PubMed |
| Elevated serum endocan levels and impaired respiratory functions in childhood asthma: a comparative study. | Allergol Immunopathol (Madr) | 2026 | 42760880 | PubTator, text mining | PubMed |
| Exploratory single-nucleus transcriptomic analysis of endothelial heterogeneity and ferroptosis-related gene patterns in a human hepatocellular carcinoma sample. | Transl Oncol | 2026 | 42759407 | PubTator, text mining | PubMed |
| Endocan Participates in TGF-β/Smad and AKT/ERK Signaling Coordination and lncRNA Modulation in Human Cardiac Fibroblasts. | Int J Mol Sci | 2026 | 42737642 | PubTator, text mining | PubMed |
| Comparison of Carotid Intima-Media Thickness and Serum Endocan Levels in Surgical and Natural Menopause With Premenopausal Women. | J Obstet Gynaecol Res | 2026 | 42733277 | PubTator, text mining | PubMed |
| The plasma protein profile of left ventricular diastolic function. | Sci Rep | 2026 | 42680832 | PubTator, text mining | PubMed |
| Serum endocan levels in patients with peripheral artery disease: an exploratory cross-sectional study. | Front Cardiovasc Med | 2026 | 42625681 | PubTator, text mining | PubMed |
1 to 10 of 2,013
See all 2,013 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/11082
GET https://conductscience.org/api/genes/v1/11082/patents?page=2